World's Best Scientists 2026 revealed!
Award Badge
Immunology
UK
2026
Award Badge
Medicine
UK
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 157 92 87 6 6 1615 108299
Medicine 158 837 768 88 82 1661 110121

David A. Isenberg publications per year

The chart shows the history of publications by David A. Isenberg between 1977 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. David A. Isenberg published across 49 years, from 1977 to 2025, averaging 36 papers a year. Output peaked at 85 publications in 2013. 71 of the 1,766 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1977 to 2025. Vertical axis: number of publications, 0 to 85. Peak 85 publications in 2013. 1977: 1 publication 1978: 1 publication 1979: 0 publications 1980: 3 publications 1981: 6 publications 1982: 13 publications 1983: 8 publications 1984: 8 publications 1985: 8 publications 1986: 13 publications 1987: 28 publications 1988: 26 publications 1989: 25 publications 1990: 22 publications 1991: 29 publications 1992: 28 publications 1993: 36 publications 1994: 42 publications 1995: 40 publications 1996: 33 publications 1997: 35 publications 1998: 30 publications 1999: 50 publications 2000: 29 publications 2001: 29 publications 2002: 44 publications 2003: 32 publications 2004: 45 publications 2005: 48 publications 2006: 33 publications 2007: 38 publications 2008: 58 publications 2009: 32 publications 2010: 62 publications 2011: 54 publications 2012: 55 publications 2013: 85 publications 2014: 75 publications 2015: 63 publications 2016: 58 publications 2017: 61 publications 2018: 64 publications 2019: 47 publications 2020: 59 publications 2021: 63 publications 2022: 38 publications 2023: 38 publications 2024: 51 publications 2025: 20 publications
1977 2025

1,766 publications in total across all disciplines

View publications per year as a table
David A. Isenberg: publications per year, 1977 to 2025
Year Publications
1977 1
1978 1
1979 0
1980 3
1981 6
1982 13
1983 8
1984 8
1985 8
1986 13
1987 28
1988 26
1989 25
1990 22
1991 29
1992 28
1993 36
1994 42
1995 40
1996 33
1997 35
1998 30
1999 50
2000 29
2001 29
2002 44
2003 32
2004 45
2005 48
2006 33
2007 38
2008 58
2009 32
2010 62
2011 54
2012 55
2013 85
2014 75
2015 63
2016 58
2017 61
2018 64
2019 47
2020 59
2021 63
2022 38
2023 38
2024 51
2025 20
Total 1,766
Download as CSV

David A. Isenberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David A. Isenberg sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 807+ publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 1,615 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100 1,615
Download as CSV

David A. Isenberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David A. Isenberg sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 157+ D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 157 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96 157
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in United Kingdom Leader Award
  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Immunology in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

David A. Isenberg is affiliated with University College London in the United Kingdom. Their research primarily focuses on the field of Medicine, with significant contributions in Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, and Genetics.

Their recent scholarly publications include the following works:

  • "2021 DORIS definition of remission in SLE: final recommendations from an international task force" (2021), published in Lupus Science & Medicine
  • "Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis" (2020), published in Journal of Thrombosis and Haemostasis
  • "16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends" (2020), published in Lupus
  • "Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial" (2021), published in Arthritis & Rheumatology
  • "British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy" (2022), published by Lara D. Veeken

The scientist has frequently collaborated with the following co-authors:

  • Anisur Rahman
  • Caroline Gordon
  • Ian N Bruce
  • Michelle Petri
  • Cynthia Aranow

Their publications have appeared regularly in several academic venues, with notable frequency in:

  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • UNC Libraries
  • Poster presentations
  • Lupus

The research topics addressed by David A. Isenberg encompass:

  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Atherosclerosis and Cardiovascular Diseases
  • T-cell and B-cell Immunology
  • Chronic Lymphocytic Leukemia Research
  • Systemic Sclerosis and Related Diseases
  • Lymphoma Diagnosis and Treatment

David A. Isenberg has been awarded the title of Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

    Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon

  • The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

    Dafna Gladman;Ellen Ginzler;Charles Goldsmith;Paul Fortin

  • The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

    Matthew H. Liang;Michael Corzillius;Sang Cheol Bae;Robert A. Lew

  • Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

    Claudio Vitali;Stefano Bombardieri;Haralampos M. Moutsopoulos;Genesio Balestrieri

  • Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial

    Joan T. Merrill;C. Michael Neuwelt;Daniel J. Wallace;Joseph C. Shanahan

  • CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

    Paul A. Blair;Lina Yassin Noreña;Fabian Flores-Borja;David J. Rawlings

  • Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

    Michael R. Ehrenstein;Jamie G. Evans;Animesh Singh;Samantha Moore

  • Mortality in systemic lupus erythematosus.

    S. Bernatsky;J. F. Boivin;L. Joseph;S. Manzi

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer

  • EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

    G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri

  • Systemic Lupus Erythematosus

    Caroline Gordon;Caroline Gordon;Caroline Gordon;Charles K. Li;Charles K. Li;Charles K. Li;David A. Isenberg;David A. Isenberg;David A. Isenberg

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Systemic lupus erythematosus.

    Larissa Lisnevskaia;Grainne Murphy;David Isenberg

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

    Tak Mao Chan;Fu Keung Li;Colin S.O. Tang;Raymond W.S. Wong

  • The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

    E.M. Hay;P.A. Bacon;C. Gordon;D.A. Isenberg

  • BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

    D. A. Isenberg;A. Rahman;E. Allen;V. Farewell

  • Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

    Ernest Choy;D A Isenberg;Toby Garrood;S Farrow

  • The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.

    Dafna D. Gladman;Murray B. Urowitz;Charles H. Goldsmith;Paul Fortin

  • An open study of B lymphocyte depletion in systemic lupus erythematosus

    Maria J. Leandro;Jonathan C. Edwards;Geraldine Cambridge;Michael R. Ehrenstein

Frequent Co-Authors

Caroline Gordon
Caroline Gordon University of Birmingham
Ian N. Bruce
Ian N. Bruce University of Manchester
Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine
Murray B. Urowitz
Murray B. Urowitz University of Toronto
Munther A. Khamashta
Munther A. Khamashta King's College London
Paul R. Fortin
Paul R. Fortin Université Laval
Rosalind Ramsey-Goldman
Rosalind Ramsey-Goldman Northwestern University
Daniel J. Wallace
Daniel J. Wallace Cedars-Sinai Medical Center
Ann E. Clarke
Ann E. Clarke University of Calgary
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens various doors to healthcare professions, with many students exploring related nursing and clinical fields. For those considering a swift transition into nursing, accelerated fnp programs offer an efficient pathway to becoming a Family Nurse Practitioner. These programs are designed for those looking to advance quickly while gaining specialized skills.

If you're starting without a nursing background, several options can help you enter the field. Notably, the best online bsn programs for non nurses provide flexibility for individuals seeking a Bachelor of Science in Nursing (BSN) remotely. These programs accommodate busy schedules and diverse learning styles.

For students eager to complete their education within a shorter timeframe, 12-month accelerated nursing programs present an appealing option. These intensive courses help candidates quickly qualify for nursing roles while maintaining quality education standards.

Additionally, those interested in practical nursing roles might explore easy admission lpn programs. Licensed Practical Nurse (LPN) programs with straightforward admissions can serve as a stepping stone for a healthcare career and provide valuable hands-on experience.

Best Scientists Citing David A. Isenberg

Trending Scientists

Recently Published Articles